Studying the genetic predisposing factors in the pathogenesis of acne vulgaris

Human Immunology

Volumn 72, Issue 9, 2011, Pages 766-773

  Szabó, Kornélia ^a,b   Kemény, Lajos ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Acne vulgaris; Cross sectional studies; Molecular genetic studies; Population based studies; Twin studies

Indexed keywords

ANDROGEN; CYTOCHROME P450; FIBROBLAST GROWTH FACTOR RECEPTOR 2; I KAPPA B; INTERLEUKIN 1ALPHA; OCTAMER TRANSCRIPTION FACTOR 1; STEROID HORMONE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ACNE VULGARIS; ANDROGEN SYNTHESIS; CYTOKINE RESPONSE; GENE EXPRESSION; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; INNATE IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STEROID METABOLISM; VARIABLE NUMBER OF TANDEM REPEAT;

ACNE VULGARIS; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; GENETIC PREDISPOSITION TO DISEASE; GONADAL STEROID HORMONES; HUMANS; INTERLEUKIN-1ALPHA; MINISATELLITE REPEATS; POLYMORPHISM, GENETIC; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84860389866     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.05.012     Document Type: Review

References (99)

1. Zouboulis C.C., Eady A., Philpott M., Goldsmith L.A., Orfanos C., Cunliffe W.C., et al. What is the pathogenesis of acne?. Exp Dermatol 2005, 14:143-152.
2. Koreck A., Pivarcsi A., Dobozy A., Kemény L. The role of innate immunity in the pathogenesis of acne. Dermatology (Basel) 2003, 206:96-105.
3. Hecht H. Hereditary trends in acne vulgaris. Prevention of acne. Dermatologica 1960, 121:297-307.
4. Siemens H.W. Die Vererbung in der Aetiologie der Hautkrankheiten. Handbuch der Haut-und Geschlechtskrankheiten 1929, J Springer, Berlin. J. Jadassohn (Ed.).
5. Siemens H.W. Die Zwillingspathologie, Ihre Bedeutung, Ihre Methodik, Ihre Bisherigen Ergebnisse 1924, J. Springer, Berlin.
6. Niermann H. Report on 230 twins with skin diseases. Z Mensch Vererb Konstitutionsl 1958, 34:483-487.
7. Friedman G.D. Twin studies of disease heritability based on medical records: application to acne vulgaris. Acta Genet Med Gemellol [Roma] 1984, 33:487-495.
8. Bataille V., Snieder H., MacGregor A.J., Sasieni P., Spector T.D. The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women. J Invest Dermatol 2002, 119:1317-1322.
9. Gloor M., Hübscher M., Friederich H.C. [External treatment of acne vulgaris using tetracycline and estrogen]. Hautarzt 1974, 25:391-394.
10. Walton S., Wyatt E.H., Cunliffe W.J. Genetic control of sebum excretion and acne-a twin study. Br J Dermatol 1988, 118:393-396.
11. Stewart M.E., McDonnell M.W., Downing D.T. Possible genetic control of the proportions of branched-chain fatty acids in human sebaceous wax esters. J Invest Dermatol 1986, 86:706-708.
12. Evans D.M., Kirk K.M., Nyholt D.R., Novac C., Martin N.G. Teenage acne is influenced by genetic factors. Br J Dermatol 2005, 152:579-581.
13. Ghodsi S.Z., Orawa H., Zouboulis C.C. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol 2009, 129:2136-2141.
14. Steiner P.E. Necropsies on Okinawans: anatomic and pathologic observations. Arch Pathol 2010, 42:359-380.
15. Findlay G.H. The age incidence of common skin diseases in the white population of the Transvaal. Br J Dermatol 1967, 79:538-542.
16. Park R.G. The age distribution of common skin disorders in the Bantu of Pretoria, Transvaal. Br J Dermatol 1968, 80:758-761.
17. Schaefer O. When the Eskimo comes to town. Nutr Today 2010, 6:8-16.
18. Freyre E.A., Rebaza R.M., Sami D.A., Lozada C.P. The prevalence of facial acne in Peruvian adolescents and its relation to their ethnicity. J Adolesc Health 1998, 22:480-484.
19. Cordain L., Lindeberg S., Hurtado M., Hill K., Eaton S.B., Brand-Miller J. Acne vulgaris: a disease of Western civilization. Arch Dermatol 2002, 138:1584-1590.
20. Merimee T.J., Rimoin D.L., Cavalli-Sforza L.L. Metabolic studies in the African Pygmy. J Clin Invest 1972, 51:395-401.
21. O'Dea K. Marked improvement in carbohydrate and lipid metabolism in diabetic Australian aborigines after temporary reversion to traditional lifestyle. Diabetes 1984, 33:596-603.
22. Spielman R.S., Fajans S.S., Neel J.V., Pek S., Floyd J.C., Oliver W.J. Glucose tolerance in two unacculturated Indian tribes of Brazil. Diabetologia 1982, 23:90-93.
23. Melnik B.C., Schmitz G. Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Exp Dermatol 2009, 18:833-841.
24. Melnik B. Milk consumption: aggravating factor of acne and promoter of chronic diseases of Western societies. J Dtsch Dermatol Ges 2009, 7:364-370.
25. Duvnjak L., Duvnjak M. The metabolic syndrome-an ongoing story. J Physiol Pharmacol 2009, 60(suppl 7):19-24.
26. Choi K., Kim Y.B. Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J Intern Med 2010, 25:119-129.
27. Gonzalez-Gay M.A., Gonzalez-Juanatey C., Vazquez-Rodriguez T.R., Miranda-Filloy J.A., Llorca J. Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-alpha therapy. Ann N Y Acad Sci 2010, 1193:153-159.
28. Ebbesson S.O., Schraer C.D., Risica P.M., Adler A.I., Ebbesson L., Mayer A.M., et al. Diabetes and impaired glucose tolerance in three Alaskan Eskimo populations. The Alaska-Siberia Project. Diabetes Care 1998, 21:563-569.
29. Lucky A.W., Biro F.M., Huster G.A., Morrison J.A., Elder N. Acne vulgaris in early adolescent boys. Correlations with pubertal maturation and age. Arch Dermatol 1991, 127:210-216.
30. Lucky A.W., Biro F.M., Huster G.A., Leach A.D., Morrison J.A., Ratterman J. Acne vulgaris in premenarchal girls. An early sign of puberty associated with rising levels of dehydroepiandrosterone. Arch Dermatol 1994, 130:308-314.
31. Goulden V., McGeown C.H., Cunliffe W.J. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol 1999, 141:297-300.
32. Dreno B., Poli F. Epidemiology of acne. Dermatology (Basel) 2003, 206:7-10.
33. Paraskevaidis A., Drakoulis N., Roots I., Orfanos C.E., Zouboulis C.C. Polymorphisms in the human cytochrome P-450 1A1 gene (CYP1A1) as a factor for developing acne. Dermatology (Basel) 1998, 196:171-175.
34. Ostlere L.S., Rumsby G., Holownia P., Jacobs H.S., Rustin M.H., Honour J.W. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne. Clin Endocrinol (Oxf) 1998, 48:209-215.
35. Sawaya M.E., Shalita A.R. Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J Cutan Med Surg 1998, 3:9-15.
36. Pivarcsi A., Kemény L., Dobozy A. Innate immune functions of the keratinocytes. A review. Acta Microbiol Immunol Hung 2004, 51:303-310.
37. Kim K.C., Lillehoj E.P. MUC1 mucin: a peacemaker in the lung. Am J Respir Cell Mol Biol 2008, 39:644-647.
38. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001, 1:135-145.
39. Kumagai Y., Akira S. Identification and functions of pattern-recognition receptors. J Allergy Clin Immunol 2010, 125:985-992.
40. Pochi P.E., Strauss J.S. Sebaceous gland response in man to the administration of testosterone, delta-4-androstenedione, and dehydroisoandrosterone. J Invest Dermatol 1969, 52:32-36.
41. Unna P.G. The Histopathology of the Diseases of the Skin 1896, Clay, W. F, Edinburgh.
42. Dessinioti C., Katsambas A.D. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies. Clin Dermatol 2010, 28:2-7.
43. Kim J. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology (Basel) 2005, 211:193-198.
44. Nagy I., Pivarcsi A., Koreck A., Széll M., Urbán E., Kemény L. Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through Toll-like receptors. J Invest Dermatol 2005, 124:931-938.
45. Koreck A., Kis K., Szegedi K., Paunescu V., Cioaca R., Olariu R., et al. TLR2 and TLR4 polymorphisms are not associated with acne vulgaris. Dermatology (Basel) 2006, 213:267-269.
46. Malhotra D., Relhan V., Reddy B.S., Bamezai R. TLR2 Arg677Trp polymorphism in leprosy: revisited. Hum Genet 2005, 116:413-415.
47. Brown R.A., Gralewski J.H., Razonable R.R. The R753Q polymorphism abrogates Toll-like receptor 2 signaling in response to human cytomegalovirus. Clin Infect Dis 2009, 49:e96-e99.
48. Brown R.A., Gralewski J.H., Eid A.J., Knoll B.M., Finberg R.W., Razonable R.R. R753Q single-nucleotide polymorphism impairs Toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins. Transplantation 2010, 89:811-815.
49. Ferwerda B., McCall M.B., Verheijen K., Kullberg B.J., van der Ven A.J., van der Meer J.W., et al. Functional consequences of Toll-like receptor 4 polymorphisms. Mol Med 2008, 14:346-352.
50. Ferwerda B., McCall M.B., Alonso S., Giamarellos-Bourboulis E.J., Mouktaroudi M., Izagirre N., et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci U S A 2007, 104:16645-16650.
51. Theodoropoulos G., Carraway K.L. Molecular signaling in the regulation of mucins. J Cell Biochem 2007, 102:1103-1116.
52. Hanisch F.G., Müller S. MUC1: the polymorphic appearance of a human mucin. Glycobiology 2000, 10:439-449.
53. Ando I., Kukita A., Soma G., Hino H. A large number of tandem repeats in the polymorphic epithelial mucin gene is associated with severe acne. J Dermatol 1998, 25:150-152.
54. Costa N.R., Mendes N., Marcos N.T., Reis C.A., Caffrey T., Hollingsworth M.A., et al. Relevance of MUC1 mucin variable number of tandem repeats polymorphism in H pylori adhesion to gastric epithelial cells. World J Gastroenterol 2008, 14:1411-1414.
55. Pomerantz J.L., Baltimore D. Two pathways to NF-kappaB. Mol Cell 2002, 10:693-695.
56. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999, 11:443-451.
57. Waldron-Lynch F., Adams C., Shanahan F., Molloy M.G., O'Gara F. Genetic analysis of the 3' untranslated region of the tumour necrosis factor shows a highly conserved region in rheumatoid arthritis affected and unaffected subjects. J Med Genet 1999, 36:214-216.
58. Knight J.C. Regulatory polymorphisms underlying complex disease traits. J Mol Med 2005, 83:97-109.
59. Smith A.J., Humphries S.E. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009, 20:43-59.
60. Baz K., Emin E.M., Yazici A.C., Soylemez F., Guvenc U., Tasdelen B., et al. Association between tumor necrosis factor-alpha gene promoter polymorphism at position -308 and acne in Turkish patients. Arch Dermatol Res 2008, 300:371-376.
61. Szabó K., Tax G., Teodorescu-Brinzeu D., Koreck A., Kemény L. TNFα gene polymorphisms in the pathogenesis of acne vulgaris. Arch Dermatol Res 2011, 303:19-27.
62. Sobjanek M., Zabłotna M., Nedoszytko B., Sokołowska-Wojdyło M., Włodarkiewicz A. Lack of association between the promoter polymorphisms at positions -238 and -308 of the tumour necrosis factor alpha gene and acne vulgaris in Polish patients. J Eur Acad Dermatol Venereol 2009, 23:331-332.
63. van Heel D.A., Udalova I.A., De Silva A.P., McGovern D.P., Kinouchi Y., Hull J., et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet 2002, 11:1281-1289.
64. Ferguson L.R., Huebner C., Petermann I., Gearry R.B., Barclay M.L., Demmers P., et al. Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World J Gastroenterol 2008, 14:4652-4661.
65. Guy R., Green M.R., Kealey T. Modeling acne in vitro. J Invest Dermatol 1996, 106:176-182.
66. Aldana O.L., Holland D.B., Cunliffe W.J. Variation in pilosebaceous duct keratinocyte proliferation in acne patients. Dermatology (Basel) 1998, 196:98-99.
67. Guy R., Kealey T. The effects of inflammatory cytokines on the isolated human sebaceous infundibulum. J Invest Dermatol 1998, 110:410-415.
68. Cunliffe W.J., Holland D.B., Clark S.M., Stables G.I. Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol 2000, 142:1084-1091.
69. Ingham E., Eady E.A., Goodwin C.E., Cove J.H., Cunliffe W.J. Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 1992, 98:895-901.
70. Szabó K., Tax G., Kis K., Szegedi K., Teodorescu-Brinzeu D.G., Diószegi C., et al. Interleukin-1A +4845(G>T) polymorphism is a factor predisposing to acne vulgaris. Tissue Antigens 2010, 76:411-415.
71. Kobayashi Y., Yamamoto K., Saido T., Kawasaki H., Oppenheim J.J., Matsushima K. Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1alpha. Proc Natl Acad Sci U S A 1990, 87:5548-5552.
72. Mosley B., Urdal D.L., Prickett K.S., Larsen A., Cosman D., Conlon P.J., et al. The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. J Biol Chem 1987, 262:2941-2944.
73. Lee S., Temple S., Roberts S., Price P. Complex effects of IL1A polymorphism and calpain inhibitors on interleukin 1 alpha (IL-1 alpha) mRNA levels and secretion of IL-1 alpha protein. Tissue Antigens 2008, 72:67-71.
74. Kawaguchi Y., Tochimoto A., Hara M., Kawamoto M., Sugiura T., Saito S., et al. Contribution of single nucleotide polymorphisms of the IL1A gene to the cleavage of precursor IL-1alpha and its transcription activity. Immunogenetics 2007, 59:441-448.
75. Zouboulis C.C., Chen W.C., Thornton M.J., Qin K., Rosenfield R. Sexual hormones in human skin. Horm Metab Res 2007, 39:85-95.
76. George R., Clarke S., Thiboutot D. Hormonal therapy for acne. Semin Cutan Med Surg 2008, 27:188-196.
77. Kurokawa I., Danby F.W., Ju Q., Wang X., Xiang L.F., Xia L., et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol 2009, 18:821-832.
78. Randall V.A. Androgens and hair growth. Dermatol Ther 2008, 21:314-328.
79. Choong C.S., Wilson E.M. Trinucleotide repeats in the human androgen receptor: a molecular basis for disease. J Mol Endocrinol 1998, 21:235-257.
80. Stanford J.L., Just J.J., Gibbs M., Wicklund K.G., Neal C.L., Blumenstein B.A., et al. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 1997, 57:1194-1198.
81. Yang Z., Yu H., Cheng B., Tang W., Dong Y., Xiao C., et al. Relationship between the CAG repeat polymorphism in the androgen receptor gene and acne in the Han ethnic group. Dermatology (Basel) 2009, 218:302-306.
82. Pang Y., He C.D., Liu Y., Wang K.B., Xiao T., Wang Y.K., et al. Combination of short CAG and GGN repeats in the androgen receptor gene is associated with acne risk in North East China. J Eur Acad Dermatol Venereol 2008, 22:1445-1451.
83. Roberts E.S., Vaz A.D., Coon M.J. Role of isozymes of rabbit microsomal cytochrome P-450 in the metabolism of retinoic acid, retinol, and retinal. Mol Pharmacol 1992, 41:427-433.
84. Zouboulis C.C., Korge B., Akamatsu H., Xia L.Q., Schiller S., Gollnick H., et al. Effects of 13-cis-retinoic acid, all-trans-retinoic acid, and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro. J Invest Dermatol 1991, 96:792-797.
85. Zouboulis C.C., Korge B.P., Mischke D., Orfanos C.E. Altered proliferation, synthetic activity, and differentiation of cultured human sebocytes in the absence of vitamin A and their modulation by synthetic retinoids. J Invest Dermatol 1993, 101:628-633.
86. Kawajiri K., Watanabe J., Gotoh O., Tagashira Y., Sogawa K., Fujii-Kuriyama Y. Structure and drug inducibility of the human cytochrome P-450c gene. Eur J Biochem 1986, 159:219-225.
87. Crofts F., Taioli E., Trachman J., Cosma G.N., Currie D., Toniolo P., et al. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 1994, 15:2961-2963.
88. Miller W.L. Early steps in androgen biosynthesis: from cholesterol to DHEA. Baillieres Clin Endocrinol Metab 1998, 12:67-81.
89. Carey A.H., Waterworth D., Patel K., White D., Little J., Novelli P., et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994, 3:1873-1876.
90. Bugano D.D., Conforti-Froes N., Yamaguchi N.H., Baracat E.C. Genetic polymorphisms, the metabolism of estrogens and breast cancer: a review. Eur J Gynaecol Oncol 2008, 29:313-320.
91. Price D.K., Franks M.E., Figg W.D. Genetic variations in the vitamin D receptor, androgen receptor and enzymes that regulate androgen metabolism. J Urol 2004, 171:S45-S49.
92. He L., Yang Z., Yu H., Cheng B., Tang W., Dong Y., et al. The relationship between CYP17 -34T/C polymorphism and acne in Chinese subjects revealed by sequencing. Dermatology (Basel) 2006, 212:338-342.
93. Nedelcheva K.V., Haraldsen E.K., Anderson K.B., Lonning P.E., Erikstein B., et al. CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1. Cancer Res 1999, 59:2825-2828.
94. Melnik B.C. Role of FGFR2-signaling in the pathogenesis of acne. Dermatoendocrinology 2009, 1:141-156.
95. Munro C.S., Wilkie A.O. Epidermal mosaicism producing localised acne: somatic mutation in FGFR2. Lancet 1998, 352:704-705.
96. Melnik B.C., Vakilzadeh F., Aslanidis C., Schmitz G. Unilateral segmental acneiform naevus: a model disorder towards understanding fibroblast growth factor receptor 2 function in acne?. Br J Dermatol 2008, 158:1397-1399.
97. Berra B., Rizzo A.M. Glycemic index, glycemic load: new evidence for a link with acne. J Am Coll Nutr 2009, 28(suppl):450S-454S.
98. Melnik B.C. Acneigenic stimuli converge in phosphoinositol-3 kinase/Akt/FoxO1 signal transduction. Clin Exp Dermatol 2010, 1:101.
99. López-Jaramillo P., Silva S.Y., Rodríguez-Salamanca N., Duràn A., Mosquera W., Castillo V. Are nutrition-induced epigenetic changes the link between socioeconomic pathology and cardiovascular diseases?. Am J Ther 2008, 15:362-372.